Should Biosimilars Be Cheap? Sponsors Aren't So Sure

 
• By Michael Cipriano
  
Limbo Dancer_507428125_1200.jpg
Biosimilar sponsors worry that going too on their prices will actually burn them.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics